Table 1.
Baseline characteristics of the trial participants.
| Parameter | ASSA group (n = 42) | MA group (n = 43) | P value |
|---|---|---|---|
| Age (years), mean (SD) | 58.52 (9.04) | 60.02 (8.14) | 0.460 |
| Gender, no. (%) | |||
| Male | 21 (50.00%) | 11 (25.58%) | 0.020 |
| Female | 21 (50.00%) | 32 (74.42%) | |
| BMI (kg/m2), mean (SD) | 23.80 (2.78) | 24.28 (4.59) | 1.000 |
| Injury cause, no. (%) | |||
| Sports injury | 6 (14.29%) | 3 (6.98%) | 0.028 |
| Fall injury | 14 (33.33%) | 4 (9.30%) | |
| Traffic injury | 1 (2.38%) | 3 (6.98%) | |
| Others | 5 (11.90%) | 10 (23.26%) | |
| Unknown | 16 (38.10%) | 23 (53.49%) | |
| Post-injury treatment, no. (%) | |||
| Untreated | 16 (38.10%) | 20 (46.51%) | 0.432 |
| Conservative treatment | 26 (61.90%) | 23 (53.49%) | - |
| Therapeutic classification | |||
| Drug | 18 (69.23%) | 16 (69.57%) | 0.750 |
| Tricot/bandage brake | 0 (0.00%) | 1 (4.35%) | |
| Others | 8 (30.77%) | 6 (26.09%) |
SD, standard deviation; BMI, body mass index.